Article

Antihypertensive medication uses and serum ACE2 levels

2020-05-25

Abstract excerpt

<h4>Importance</h4> Recent reports have shown that hypertension is the most common comorbidity associated with mortality in the current coronavirus disease 2019 (COVID-19). This has been related to the use of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) as animal studies indicate that these medications increase levels of ACE2, the cellular entry point for the coronav...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7ab9e0bd-1e28-5884-9036-4a41d0ff2bde
DOI: 10.1101/2020.05.21.20108738

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Antihypertensive medication uses and serum ACE2 levelsDOI 10.1101/2020.05.21.20108738Read

Hypertension and renin-angiotensin system blockers are not associated with expression of Angiotensin Converting Enzyme 2 (ACE2) in the kidneySemantic proximity Read

Changes in the SARS-CoV-2 cellular receptor ACE2 levels in cardiovascular patients: a potential biomarker for the stratification of COVID-19 patientsSemantic proximity Read

The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19Semantic proximity Read

COVID-19: The Influence of ACE Genotype and ACE-I and ARBs on the Course of SARS-CoV-2 Infection in Elderly Patients.Semantic proximity Read

ARB/ACEI use and severe COVID-19: a nationwide case-control studySemantic proximity Read

The Race for ACE: Targeting Angiotensin-Converting Enzymes (ACE) in SARS-CoV-2 InfectionSemantic proximity Read

Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19?Semantic proximity Read

ACE inhibitors, AT1 receptor blockers and COVID-19: clinical epidemiology evidences for a continuation of treatments. The ACER-COVID studySemantic proximity Read

Level of the SARS-CoV-2 receptor ACE2 activity is highly elevated in old-aged patients with aortic stenosis: implications for ACE2 as a biomarker for the severity of COVID-19Semantic proximity Read

Currently prescribed drugs in the UK that could up or downregulate ACE2 in COVID-19 disease: A systematic reviewSemantic proximity Read

A Low Aldosterone/Renin Ratio and High Soluble ACE2 Associate with COVID-19 SeveritySemantic proximity Read

Renin-angiotensin system blockers and susceptibility to COVID-19: a multinational open science cohort studySemantic proximity Read